Imaging of neuroendocrine tumors: Accuracy of helical CT versus SRS

Abdominal Imaging

Volumn 29, Issue 6, 2004, Pages 696-702

  Kumbasar, B ^a   Kamel, I R ^a   Tekes, A ^a   Eng, J ^a   Fishman, E K ^a   Wahl, R L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Helical computed tomography; Neuroendocrine tumors; Scintigraphy

Indexed keywords

IOHEXOL; PENTETREOTIDE; PENTETREOTIDE IN 111;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SCINTIGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ADENOMA, ISLET CELL; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INTESTINAL NEOPLASMS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 4944256634     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-003-0162-3     Document Type: Article

References (27)

1. Pearse AG (1969) The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 17:303-313
2. Lobrano MB, McCarthy K, Adams L, Neitzschman H (1997) Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report. Am J Gastroenterol 92:513-515
3. Perry RR, Vinik AI (1996) Endocrine tumors of the gastrointestinal tract. Annu Rev Med 47:57-68
4. Kwekkeboom DJ, Lamberts SW, Habbema JD, Krenning EP (1996) Cost-effectiveness analysis of somatostatin receptor scintigraphy. J Nucl Med 37:886-892
5. King CM, Reznek RH, Bomanji J, et al. (1993) Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study. Clin Radiol 48:386-391
6. Shi W, Johnston CF, Buchanan KD, et al. (1998) Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. QJM 91:295-301
7. Kamel IR, Choti MA, Horton KM, et al. (2003) Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 227:752-757
8. Hopper KD, Singapuri K, Finkel A (2000) Body CT and oncologic imaging. Radiology 215:27-40
9. Valls C, Andia E, Sanchez A, et al. (2001) Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 218:55-60
10. Frucht H, Doppman JL, Norton JA, et al. (1989) Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology 171:713-717
11. Slooter GD, Mearadji A, Breeman WA, et al. (2001) Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. Br J Surg 88:31-40
12. Kvols LK, Buck M, Moertel CG, et al. (1987) Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med 107:162-168
13. Mahler C, Verhelst J, de Longueville M, Harris A (1990) Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide. Clin Endocrinol (Oxf) 33:261-269
14. Fishman EK (2001) From the RSNA refresher courses: CT angiography: clinical applications in the abdomen. Radiographics 21:S3-S16
15. Rydberg J, Buckwalter KA, Caldemeyer KS, et al. (2000) Multisection CT: scanning techniques and clinical applications. Radiographics 20:1787-1806
16. Ji H, McTavish JD, Mortele KJ, et al. (2001) Hepatic imaging with multidetector CT. Radiographics 21:S71-S80
17. Lamberts SW, Reubi JC, Bakker WH, Krenning EP (1990) Somatostatin receptor imaging with 123I-Tyr3-octreotide. Z Gastroenterol 28(suppl 2):20-21
18. Kisker O, Weinel RJ, Geks J, et al. (1996) Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids. World J Surg 20:162-167
19. Scherubl H, Bader M, Fett U, et al. (1993) Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology 105:1705-1709
20. Schillaci O, Spanu A, Scopinaro F, et al. (2003) Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med 44:359-368
21. Lebtahi R, Cadiot G, Sarda L, et al. (1997) Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 38:853-858
22. Krausz Y, Bar-Ziv J, de Jong RB, et al. (1998) Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Am J Gastroenterol 93:66-70
23. Briganti V, Matteini M, Ferri P, et al. (2001) Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors. Cancer Biother Radiopharm 16:515-524
24. Chiti A, Fanti S, Savelli G, et al. (1998) Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med 25:1396-1403
25. Lamberts SW, Reubi JC, Krenning EP (1993) Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors. Acta Oncol 32:167-170
26. Krenning EP, Kwekkeboom DJ, Bakker WH, et al. (1993) Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1] and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716-731
27. Oliaro A, Filosso PL, Bello M, et al. (1997) Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results. J Cardiovasc Surg (Torino) 38:313-315